After a 2022–2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French Government launched a preventive immunization campaign, administering nirsevimab (Beyfortus), to protect infants and reduce the circulation of the virus.
from Medical Xpress - latest medical and health news stories https://ift.tt/t0XB2Io
